MedTrace Logo

Sex Hormones & Serum Sclerostin Level

NCT01418924 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2011-10-20

No results posted yet for this study

Summary

The aim of this study is to determine whether plasma sclerostin levels is affected by sex hormones during menstrual cycle. Blood samples will be obtained at the beginning (between 2-5th day), mid (between 11-13th day) and end (between 21-23th day) of menstrual cycle. Serum sclerostin, estradiol, progesterone and testosteron levels will be measured blindly by only one investigator

Conditions

  • Bony Sclerosis
  • Testicular; Hormone, C

Sponsors & Collaborators

  • Bagcilar Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • MUHARREM CIDEM, MD · Bagcilar Training & Research Hospital Istanbul, Turkey

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-09-30
Completion
2011-10-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01418924 on ClinicalTrials.gov